ETR:RHK RHÖN-KLINIKUM Aktiengesellschaft (RHK) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChart About RHÖN-KLINIKUM Aktiengesellschaft Stock (ETR:RHK) 30 days 90 days 365 days Advanced Chart Ad Chaikin AnalyticsBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, with annual revenue up nearly 100%. So why did the stock abruptly plunge following the earnings release – losing $175 billion in just 8 minutes?Things are about to get even stranger. Get RHK alerts:Sign Up Key Stats Today's Range N/A50-Day Range€10.90▼€12.9052-Week Range N/AVolume380 shsAverage Volume43,281 shsMarket Capitalization$843.44 millionP/E Ratio18.00Dividend Yield1.21%Price TargetN/AConsensus RatingN/A Company OverviewRHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.Read More… BREAKING: NVDA loses $175 billion in 8 minutes (Ad)It's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, with annual revenue up nearly 100%. So why did the stock abruptly plunge following the earnings release – losing $175 billion in just 8 minutes?Things are about to get even stranger. Receive RHK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address RHK Stock News HeadlinesZukunft des UKGM: Rhön-Klinikum stellt Einigung infrageMay 12, 2022 | finanznachrichten.deRhön-Klinikum kommt gut durchs Corona-Jahr 2021March 25, 2022 | finanznachrichten.deDemocrats Sold Out the American Dream - Are you ready?There's a massive housing crisis looming, and nobody on Main Street knows it yet... The Democrats sold out the American Dream - and now, millions of Americans are locked out of the housing market, forced to become "permanent renters."November 22, 2024 | Behind the Markets (Ad)RHÖN-KLINIKUM AG looks back on successful financial year 2021March 25, 2022 | uk.finance.yahoo.comWarum Technik und Medizin gut zusammenpassen - RHÖN fördert praxisorientierte Studien- und BerufsorientierungFebruary 19, 2022 | finanznachrichten.deRHÖN-KLINIKUM Campus Bad Neustadt ist TAVI-ZentrumFebruary 19, 2022 | finanznachrichten.deSee More Headlines RHK Stock Analysis - Frequently Asked Questions What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft own? Based on aggregate information from My MarketBeat watchlists, some other companies that RHÖN-KLINIKUM Aktiengesellschaft investors own include Seabridge Gold (SA), Walt Disney (DIS), Barrick Gold (GOLD), iShares Silver Trust (SLV), Alamos Gold (AGI), Anheuser-Busch InBev SA/NV (BUD) and Gilead Sciences (GILD). Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolETR:RHK CUSIPN/A CIKN/A Webwww.rhoen-klinikum-ag.com Phone+49-9-771650FaxN/AEmployees18,324Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€0.70 Trailing P/E Ratio18.00 Forward P/E RatioN/A P/E Growth26.77Net Income$46.53 million Net Margins2.58% Pretax MarginN/A Return on Equity3.80% Return on Assets1.59% Debt Debt-to-Equity Ratio11.59 Current Ratio2.34 Quick Ratio2.12 Sales & Book Value Annual Sales$1.80 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.75 Book Value€19.01 per share Price / BookN/AMiscellaneous Outstanding Shares66,940,000Free FloatN/AMarket Cap$843.44 million OptionableNot Optionable Beta-0.13 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (ETR:RHK) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RHÖN-KLINIKUM Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share RHÖN-KLINIKUM Aktiengesellschaft With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.